Daré Bioscience And Premier Research Have Extended Their Partnership Agreement To Continue Providing On An Exclusive Basis Contract Research Organization Services Within The US To Support The Clinical Development Of Daré's Reproductive Health Portfolio
Portfolio Pulse from Benzinga Newsdesk
Daré Bioscience has extended its exclusive partnership agreement with Premier Research to continue receiving contract research organization services in the US for its reproductive health portfolio. The original agreement was with Health Decisions, Inc., which Premier Research acquired in 2021.
November 20, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Daré Bioscience's extension of its partnership with Premier Research is expected to provide continued support for its reproductive health portfolio's clinical development in the US.
The extension of the partnership with Premier Research is likely to be viewed positively by investors as it ensures ongoing support for Daré's clinical development efforts. This could lead to progress in their reproductive health portfolio, potentially increasing investor confidence and the stock's value in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80